Kinarus Therapeutics Holding AG
SIX:CURN

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:CURN
Watchlist
Price: 11.8 CHF -2.48% Market Closed
Market Cap: 58.9m CHF

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of CURN.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CURN Intrinsic Value
Not Available
Base Case Scenario
Compare CURN to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about KNRS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Kinarus Therapeutics Holding AG

Balance Sheet Decomposition
Kinarus Therapeutics Holding AG

Current Assets 111k
Receivables 108k
Other Current Assets 3k
Current Liabilities 275k
Accounts Payable 56k
Accrued Liabilities 86k
Other Current Liabilities 133k
Non-Current Liabilities -1k
Other Non-Current Liabilities -1k
Efficiency

Free Cash Flow Analysis
Kinarus Therapeutics Holding AG

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Kinarus Therapeutics Holding AG

Revenue
0 CHF
Operating Expenses
-13.9m CHF
Operating Income
-13.9m CHF
Other Expenses
-6k CHF
Net Income
-13.9m CHF
Fundamental Scores

CURN Profitability Score
Profitability Due Diligence

Kinarus Therapeutics Holding AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Negative 3Y Average Operating Margin
hidden
Profitability
Score

Kinarus Therapeutics Holding AG's profitability score is hidden . The higher the profitability score, the more profitable the company is.

CURN Solvency Score
Solvency Due Diligence

Kinarus Therapeutics Holding AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Low D/E
Long-Term Solvency
Short-Term Solvency
hidden
Solvency
Score

Kinarus Therapeutics Holding AG's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CURN Price Targets Summary
Kinarus Therapeutics Holding AG

There are no price targets for CURN.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Kinarus Therapeutics Holding AG
does not pay dividends
Shareholder Yield

Current shareholder yield for KNRS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y